Risk-adjusted chemoradiation according to human papilloma viral status for anal cancer: a pilot study

Risk-adjusted chemoradiation according to human papilloma viral status for anal cancer: a pilot study

Background and purposeHPV-associated or positive (HPV+) anal cancer patients may have better outcome compared to those with HPV negative (HPV−) disease. We report a planned interim analysis of a prospective registry study that tailors chemoradiation (CRT) for anal cancer according to HPV status.Mate...

Full description

Bibliographic Details
Main Authors: William Chu, Amandeep Taggar, Yee Ung, Kelvin K. W. Chan, Craig C. Earle, Aliaksandr Karotki, Mark Pasetka, Joe Presutti, John Wong, Liying Zhang, C. Shun Wong
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Oncology
Subjects:
anal cancer
human papilloma virus
chemoradiation
risk-adjusted therapy
IMRT
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1183854/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1183854/full

Similar Items